A detailed history of Pdt Partners, LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 60,669 shares of TGTX stock, worth $1.96 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
60,669
Holding current value
$1.96 Million
% of portfolio
0.14%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$17.21 - $25.28 $1.04 Million - $1.53 Million
60,669 New
60,669 $1.42 Million
Q3 2022

Nov 14, 2022

SELL
$4.57 - $8.4 $381,412 - $701,064
-83,460 Reduced 58.81%
58,466 $346,000
Q2 2022

Aug 15, 2022

BUY
$3.74 - $10.66 $530,803 - $1.51 Million
141,926 New
141,926 $603,000
Q1 2020

May 15, 2020

SELL
$7.14 - $15.99 $204,175 - $457,250
-28,596 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$5.1 - $11.2 $145,839 - $320,275
28,596 New
28,596 $317,000

Others Institutions Holding TGTX

About TG THERAPEUTICS, INC.


  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.69B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Pdt Partners, LLC Portfolio

Follow Pdt Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.